SynthesisJournal of neuro-oncology2025
The relationship between extent of resection, tumor recurrence, and facial nerve outcomes in vestibular schwannoma surgery: a single-institution experience and systematic review.
Synthesis in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The interaction of regulated forms of cell death in the pathogenesis of severe facial paralysis and potential therapeutic strategies.Frontiers in neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGross surgical resection (GTR) of vestibular schwannomas (VS) is curative, but how surgical intent translates to facial nerve outcomes in practice, however, is incompletely understood. The purpose of this study was to identify factors predicting tumor recurrence in our contemporary VS cohort and explore existing literature regarding extent of resection and facial nerve outcomes.
methodsIn this retrospective study, we reviewed outcomes for 451 VS patients who underwent surgical resection at our institution between July 2016 and April 2024. We collected data on demographics, intraoperative clinical characteristics, and postoperative outcomes. A systematic review of all existing VS literature was conducted to compare rates of GTR to rates of preserved facial nerve function.
resultsA multivariable analysis found that larger tumor size increased the risk of recurrence [hazard ratio (HR): 1.903, 95% confidence interval (CI): 1.163-3.113, p = 0.010] and GTR decreased the risk of recurrence (HR: 0.022, 95% CI: 0.003-0.169, p < 0.001). Additionally, a systematic analysis of data extracted from 75 VS studies showed an inverse relationship between rate of GTR and good facial nerve outcomes, but only in series that reported a rate of at least 75% GTR.
conclusionOur data indicate that the risk of tumor recurrence decreases with GTR. Using rate of GTR as a surrogate for surgical intent in institutional studies, we found that the rate of GTR correlates with facial nerve outcomes only in the most surgically aggressive series. Overall, these data support a strategy individualized to each patient that is refined based on intraoperative findings.
Indexed as
Identifiers
41162807What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.